https://checkorphan.org/news/sangrail-biologics-launches-with-lead-gene-therapy-sng-101-for-mucopolysaccharidosis-type-iiib-showing-promising-phase-1-2-results/
Sangrail Biologics Launches with Lead Gene Therapy SNG-101 For Mucopolysaccharidosis Type IIIB...
https://www.packgene.com/frontier/050526-sangrail-biologics/
Sangrail Biologics Launches with Lead AAV9 Gene Therapy Program for MPS IIIB | PackGene Biotech